54 research outputs found

    Progress in the Prediction of Entropy Generation in Turbulent Reacting Flows Using Large Eddy Simulation

    Get PDF
    An overview is presented of the recent developments in the application of large eddy simulation (LES) for prediction and analysis of local entropy generation in turbulent reacting flows. A challenging issue in such LES is subgrid-scale (SGS) modeling of filtered entropy generation terms. An effective closure strategy, recently developed, is based on the filtered density function (FDF) methodology with inclusion of entropy variations. This methodology, titled entropy FDF (En-FDF), is the main focus of this article. The En-FDF has been introduced as the joint velocity-scalar-turbulent frequency-entropy FDF and the marginal scalar-entropy FDF. Both formulations contain the chemical reaction and its entropy generation effects in closed forms. The former constitutes the most comprehensive form of the En-FDF and provides closure for all of the unclosed terms in LES transport equations. The latter is the marginal En-FDF and accounts for entropy generation effects, as well as scalar-entropy statistics. The En-FDF methodologies are described, and some of their recent predictions of entropy statistics and entropy generation in turbulent shear flows are presented

    Effect of gypsum on potassium and iron release from phlogopite under laboratory conditions

    Get PDF
    This study estimated the effects of gypsum on the potassium and iron release rate from phlogopite under laboratory conditions. A randomized design with the factorial arrangement and three replications was utilized to run the current experiment. Treatments included different levels of gypsum (0, 2, 5, 12 and 25%) and eight different time periods (12 hours, 1, 2, 4, 8, 16, 32 and 64 days). The result of this study indicated that the rate of potassium and iron release were faster initially, and it slowed down thereafter. As gypsum content increased, potassium and iron concentrations decreased which is haply due to immense presence of calcium ions. Calcium ions change the equilibrium of K by increasing the amount of gypsum. The results revealed that the potassium and iron release rate from phlogopite is drastically declined in the presence of gypsum

    Evaluation of Skills and Use of Computer and Internet among Professors, Postgraduate and Undergraduate Students in Kerman, Iran

    Get PDF
    Background & Objective: In the 21 century using computers and the internet are necessary. Computers and internet provide professors and students with the possibility of accessing scientific information very quickly. The aim of this study was the evaluation of skills and use of computer and internet among professors, and postgraduate and undergraduate students in Kerman University of Medical Sciences, School of Dentistry. Methods: In this cross-sectional and descriptive-analytic study a questionnaire was given to 51 professors, 42 postgraduate and 241 undergraduate dental students of Kerman University of Medical Sciences. After completing the questionnaires, data were analyzed using chi-square test. Results: Statistical analysis showed that the rate of access to computers at home and universities among professors, and post- and undergraduate students was 88.2%, 84.7%, 85.4%, respectively. 98% of professors, 95% of postgraduates, and 94% of undergraduate students use the internet. The most rate of computer use was 0.5-2 hours during the day. 87.4% of professors, 71.4% of postgraduates, and 71% of undergraduate students do not need education for using the internet. Professors and assistants use of computers for academic activities was higher than students. Conclusion: Skills and use rate of computers and internet was higher in professors in comparison with other groups and there were no statistically significant difference between men and women in three groups. Keywords Dentistry Internet Compute

    Evaluation of anxiety and professional competence of prehospital emergency medical personnel in COVID-19 pandemics

    Get PDF
    INTRODUCTION: Emergency medical services (EMS) are an important part of the health care system. Decision-making is the most important part of their profession because they often have to make quick decisions and act on them despite critical situations. They are often the first to deal with a Coronavirus disease 2019 (COVID-19) patient and experience severe physical, mental, or moral stress. The aim of this study was to investigate the level of anxiety and professional competence of prehospital emergency medical personnel in the COVID-19 epidemics. MATERIAL AND METHODS: This descriptive-analytical study was performed in 2021. A total of 200 prehospital emergency medical personnel were included in the study. Sampling method was census using a valid questionnaire of Corona Anxiety Scale and professional competence. Data analysis was performed using SPSS statistical software version 21 via descriptive statistics and analytical tests. RESULTS: Mean and standard deviation of professional competence and anxiety of emergency medical staff were reported as 82.37 ± 65.13 and 98.17 ± 11.11, respectively. The results of the study on the relationship between the scores of the studied variables showed a significant relationship so that the level of anxiety with competence was remarkably related (p < 0.05). CONCLUSIONS: The stress and anxiety of the COVID-19 epidemic might have adverse effects on the professional competence of prehospital emergency medical personnel as well as their mental health. Applying strategies to reduce anxiety and attending disaster-related courses could help the quality of EMS by improving professional competence

    Evaluating the level of professional moral courage of pre-hospital emergency staff in the management of patients with COVID-19

    Get PDF
    Background. Emergency Medical Services (EMS) are an important part of the healthcare system. Decision making is the most important part of their profession, as they often have to make a quick decision and act upon it, despite the critical conditions of the patient. They are often the first to deal with COVID-19, and they experience severe physical, mental or moral stress. Objectives. The aim of this study was to determine the level of Professional Moral Courage (PMC) of Pre-Hospital Emergency (PHE) staff in the management of patients with COVID-19. Material and methods. This descriptive, analytical study was conducted in 2020. A total of 200 PHE staff entered the study, recruited by the census sampling method. Data collection was undertaken using a validated moral courage questionnaire. The data was analyzed using SPSS version/21 with descriptive and analytic tests. Results. The mean age of the participants was 34.42 +/- 7.14, and mean of their work experience was 10.29 +/- 6.59 years, of the mean moral courage score was 90.77 +/- 2.97. There was a significant relationship between the mean score of moral courage and age, type of employment and participation in disaster exercises and training courses (p < 0.001). Conclusions. The findings of the study showed a significant relationship between various variables and level of moral courage in PHE staff. Awareness of the moral courage of PHE staff is the first step to improve their preparedness. This study provides evidence of the need and potential positive impact of moral education opportunities for healthcare team

    Prevalence of Anaerobic Bacteria (P.gingivalis) as Major Microbial Agent in the Incidence Periodontal Diseases by Meta-analysis

    Get PDF
    Statement of the Problem: Periodontal diseases are complex oral diseases characterized by bacterial-induced inflammatory destruction of tooth-supporting tissues. Porphyromonas gingivalis (P. gingivalis) is a common gram-negative anaerobic oral bacteria strongly associated with periodontal disease. Purpose: The present study was conducted to estimate prevalence of P. gingivalis in patients with periodontal diseases by using meta-analysis method. Martials and Method: Different databases including PubMed, EmBase, Scopus, the Institute for Scientific Information (ISI) Web of Science, and the Cochrane Library were searched to identify original English-language studies addressing prevalence of P. gingivalis in periodontal diseases up to December 2014. The random effects model was applied in the meta-analysis and the heterogeneity between studies was assessed using a Cochran test and the I2 index. Funnel plots and Egger test were used to examine publication bias. Statistical analyses were performed using STATA version 12. Results: Forty-two eligible studies published during 1993- 2016 were selected for meta-analysis. Considering all the included studies, the total sample size was 5,884 individuals containing 2,576 healthy people with a mean age of 37.21±7.45 years and 3,308 periodontal patients with a mean age of 44.16±8.35 years. Overall, the prevalence of P. gingivalis was 78% [95% CI: 74-81] in periodontal diseases group and 34% [95% CI: 26-41] in healthy individuals. There was a significantly higher prevalence of P.gingivalis in individuals with periodontal diseases compared to healthy subjects [78% versus 34%, respectively]. Conclusion: This study indicates that P. gingivalis is highly present in subjects with periodontal diseases and it also appears in periodontally healthy people, although to a lesser extent. Thus, the presence of P. gingivalis increases the chance of periodontal disease and it can be considered as a main potential risk factor

    The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019

    Get PDF
    BACKGROUND: Communicable disease control has long been a focus of global health policy. There have been substantial reductions in the burden and mortality of communicable diseases among children younger than 5 years, but we know less about this burden in older children and adolescents, and it is unclear whether current programmes and policies remain aligned with targets for intervention. This knowledge is especially important for policy and programmes in the context of the COVID-19 pandemic. We aimed to use the Global Burden of Disease (GBD) Study 2019 to systematically characterise the burden of communicable diseases across childhood and adolescence. METHODS: In this systematic analysis of the GBD study from 1990 to 2019, all communicable diseases and their manifestations as modelled within GBD 2019 were included, categorised as 16 subgroups of common diseases or presentations. Data were reported for absolute count, prevalence, and incidence across measures of cause-specific mortality (deaths and years of life lost), disability (years lived with disability [YLDs]), and disease burden (disability-adjusted life-years [DALYs]) for children and adolescents aged 0-24 years. Data were reported across the Socio-demographic Index (SDI) and across time (1990-2019), and for 204 countries and territories. For HIV, we reported the mortality-to-incidence ratio (MIR) as a measure of health system performance. FINDINGS: In 2019, there were 3·0 million deaths and 30·0 million years of healthy life lost to disability (as measured by YLDs), corresponding to 288·4 million DALYs from communicable diseases among children and adolescents globally (57·3% of total communicable disease burden across all ages). Over time, there has been a shift in communicable disease burden from young children to older children and adolescents (largely driven by the considerable reductions in children younger than 5 years and slower progress elsewhere), although children younger than 5 years still accounted for most of the communicable disease burden in 2019. Disease burden and mortality were predominantly in low-SDI settings, with high and high-middle SDI settings also having an appreciable burden of communicable disease morbidity (4·0 million YLDs in 2019 alone). Three cause groups (enteric infections, lower-respiratory-tract infections, and malaria) accounted for 59·8% of the global communicable disease burden in children and adolescents, with tuberculosis and HIV both emerging as important causes during adolescence. HIV was the only cause for which disease burden increased over time, particularly in children and adolescents older than 5 years, and especially in females. Excess MIRs for HIV were observed for males aged 15-19 years in low-SDI settings. INTERPRETATION: Our analysis supports continued policy focus on enteric infections and lower-respiratory-tract infections, with orientation to children younger than 5 years in settings of low socioeconomic development. However, efforts should also be targeted to other conditions, particularly HIV, given its increased burden in older children and adolescents. Older children and adolescents also experience a large burden of communicable disease, further highlighting the need for efforts to extend beyond the first 5 years of life. Our analysis also identified substantial morbidity caused by communicable diseases affecting child and adolescent health across the world. FUNDING: The Australian National Health and Medical Research Council Centre for Research Excellence for Driving Investment in Global Adolescent Health and the Bill & Melinda Gates Foundation

    The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF
    Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

    Get PDF
    Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

    Ancient pigs reveal a near-complete genomic turnover following their introduction to Europe

    Get PDF
    Archaeological evidence indicates that pig domestication had begun by ~10,500 y before the present (BP) in the Near East, and mitochondrial DNA (mtDNA) suggests that pigs arrived in Europe alongside farmers ~8,500 y BP. A few thousand years after the introduction of Near Eastern pigs into Europe, however, their characteristic mtDNA signature disappeared and was replaced by haplotypes associated with European wild boars. This turnover could be accounted for by substantial gene flow from local Euro-pean wild boars, although it is also possible that European wild boars were domesticated independently without any genetic con-tribution from the Near East. To test these hypotheses, we obtained mtDNA sequences from 2,099 modern and ancient pig samples and 63 nuclear ancient genomes from Near Eastern and European pigs. Our analyses revealed that European domestic pigs dating from 7,100 to 6,000 y BP possessed both Near Eastern and European nuclear ancestry, while later pigs possessed no more than 4% Near Eastern ancestry, indicating that gene flow from European wild boars resulted in a near-complete disappearance of Near East ancestry. In addition, we demonstrate that a variant at a locus encoding black coat color likely originated in the Near East and persisted in European pigs. Altogether, our results indicate that while pigs were not independently domesticated in Europe, the vast majority of human-mediated selection over the past 5,000 y focused on the genomic fraction derived from the European wild boars, and not on the fraction that was selected by early Neolithic farmers over the first 2,500 y of the domestication process
    corecore